Shaping the future of vascular stenting - REVA Medical and B. Braun form new partnership
B. Braun and REVA Medical hereby announce the strategic partnership for the distribution of Fantom® Encore - a bioresorb…
B. Braun and REVA Medical hereby announce the strategic partnership for the distribution of Fantom® Encore - a bioresorb…
According to the latest report by Renub Research, titled "United States Diabetes Market, By Continuous Glucose Monitorin…
According to the latest report by Renub Research, titled "Germany Diabetes Market, By Continuous Glucose Monitoring (CGM…
At the extraordinary general meeting of RHÖN-KLINIKUM AG today the CEO directed an urgent appeal to its large shareholde…
RHÖN-KLINIKUM Aktiengesellschaft declares that the Amtsgericht (local court) in Schweinfurt has rejected the application…
On 15 May 2020, the Management Board of RHÖN-KLINIKUM Aktiengesellschaft, after careful examination, decided to reject t…
In an ad hoc notice dated 18 April 2020, RHÖN-KLINIKUM Aktiengesellschaft informed about the convocation request of the…
On 19 April 2020, the shareholder Asklepios Kliniken GmbH & Co. KGaA ("Asklepios") informed the Company, in response to…
. - Shareholders approve dividend increase by roughly 32 percent to EURO 0.29 following significant rise in EBITDA and…
At the shareholders' meeting on December 10, 2018, Mrs. Anna Maria Braun, Member of the Management Board of B. Braun Mel…